N/A
Completed N=986
Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
Source: ClinicalTrials.gov NCT06615401 ↗Enrolled (actual)
986
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcomePrimary: Receipt of Gender Affirming Treatment — 769; 687; 292; 468 Participants
Summary
Transgender Veterans (trans Vets) frequently experience gender dysphoria or distress related to discord between their gender identity and birth sex. Gender-affirming treatments (GATs) are medically necessary treatments to reduce gender dysphoria. However, not much is known about the barriers and facilitators that influence GAT access and receipt in VA and VA Community Care (CC), among trans Vets who desire GATs. The goals of this mixed-methods study are to determine which GATs trans Vets receive and in which setting, identify barriers and facilitators associated with desired GAT receipt in VA and CC, examine association of GAT receipt, specifically mental healthcare and hormone therapy, with mental health and suicide risk and understand trans Vet experiences related to receipt and desire for mental healthcare and hormone therapy in VA and CC.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Receipt of Gender Affirming Treatment |
769; 687; 292; 468; 350; 224 | — |
Eligibility Criteria
Inclusion Criteria
- All veterans with documentation of gender identity disorder diagnoses
- Self-reported gender identity as transgender and relevant transgender-related health factor
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT06615401). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.